News

Treat Autoimmune Hepatitis Based on Natural History of Disease


 

FROM A SYMPOSIUM SPONSORED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY

In those who fail therapy, it might be useful to increase prednisone to 60 mg/day and azathioprine to 150 mg/day. If there is still no response, it is worth trying mycophenolate mofetil or a calcineurin inhibitor such as tacrolimus, although these have only been assessed in small pilot studies and haven’t proved very successful. Transplant is also an option that generally works well for autoimmune hepatitis in patients who don’t respond to medical therapy and can be considered, particularly in young patients with otherwise good health, Dr. Luxon said.

Dr. Luxon had no relevant disclosures to report.

Pages

Recommended Reading

Disease Activity Higher in Obese RA Patients
MDedge Internal Medicine
RA Patients Taking Rituximab Are at Risk for PML
MDedge Internal Medicine
Updated ACR/EULAR Criteria May Result in Early RA Overdiagnosis, Overtreatment
MDedge Internal Medicine
AS Treatments May Relieve Symptoms But Not Halt Progression
MDedge Internal Medicine
Interstitial and Obstructive Lung Disease Risk, Mortality Increased in RA Patients
MDedge Internal Medicine
TRACTISS to Study Rituximab Effects in Sjögren's Syndrome
MDedge Internal Medicine
Diabetes-Induced Osteoarthritis Proposed as Possible Phenotype
MDedge Internal Medicine
Selenium Improves QOL, Slows Progression of Mild Graves’ Orbitopathy
MDedge Internal Medicine
Editorial: Compliments and Corrections
MDedge Internal Medicine
Rheumatoid Arthritis Confers Same Cardiovascular Risk as Diabetes
MDedge Internal Medicine